期刊文献+

腹膜透析相关性腹膜炎病原菌及其危险因素 被引量:15

Pathogens and risk factors of peritoneal dialysis-related peritonitis
下载PDF
导出
摘要 目的了解腹膜透析(PD)相关性腹膜炎的细菌谱和耐药情况,为合理使用抗菌药物提供依据。方法回顾性分析某医院2013年1月—2014年12月收治的120例次PD相关性腹膜炎患者的临床资料。结果细菌培养阳性91例次,阳性率为75.83%。共培养病原菌93株,其中革兰阳性(G^+)菌73株(78.49%),革兰阴性(G^-)菌13株(13.98%),最常见的菌种G^+菌是表皮葡萄球菌(38株,40.86%)和G^-菌为大肠埃希菌(3株,3.23%)。G^+菌对青霉素(93.65%)、红霉素(69.57%)和苯唑西林(64.41%)有较高的耐药率,对万古霉素(2.90%)和利奈唑胺(1.47%)耐药率较低,对替考拉宁、替加环素和呋喃妥因均敏感。G^-菌对头孢唑林(50.00%)、头孢呋辛(37.50%)和氨苄西林(37.50%)有较高的耐药率,对亚胺培南、妥布霉素、哌拉西林均敏感。G^+、G^-菌对庆大霉素和左氧氟沙星均具有较低的耐药率。换液操作不规范(56.67%)是引起腹膜炎最常见的原因,主要为G^+菌感染(79.41%);而腹泻引起的腹膜炎主要为G^-菌感染(52.63%)。G^+菌、G^-菌和细菌培养阴性腹膜炎的治愈率分别为92.96%、76.92%和86.21%,三者治愈率比较差异无统计学意义(χ~2=3.39,P=0.18)。结论 PD相关性腹膜炎的病原菌以G^+菌为主,多由于换液操作不规范使病原菌经腹透管感染。第一代头孢菌素不能作为对G^+菌的经验性用药,而万古霉素仍是最佳选择。第三代头孢菌素和氨基糖苷类可作为对G^-菌的经验性用药。特殊情况下庆大霉素和左氧氟沙星可单独作为经验性用药。 Objective To investigate the bacterial spectrum and antimicrobial resistance of peritoneal dialysis (PD)-related peritonitis,and provide evidence for rational antimicrobial use.Methods Clinical data of 120 patients with PD-related peritonitis in a hospital from January 2013 to December 2014 were retrospectively analyzed. Results 91 cases (75.83%)showed positive result in bacterial culture,93 pathogenic strains were cultured,inclu-ding 73 (78.49%)gram-positive and 13 (13.98%)gram-negative bacterial strains,the most common gram-positive bacteria was Staphylococcus epidermidis (n=38,40.86%),and the main gram-negative bacteria was Escherichia coli (n =3,3.23%).Gram-positive strains had high resistance rates to penicillin,erythromycin,and oxacillin (93.65%,69.57%,and 64.41 % respectively),while resistance rates to vancomycin and linezolid were both low (2.90% and 1 .47% respectively),and were sensitive to teicoplanin,tigecycline,and nitrofurantoin.Gram-negative bacteria had high resistance rates to cefazolin,cefuroxime,and ampicillin(50.00%,37.50%,and 37.50% respec-tively),but were sensitive to imipenem,tobramycin,and piperacillin.Resistance rates of gram-positive and gram-negative bacteria to gentamicin and levofloxacin were both low.Non-standard operation during dialysate exchange was the most common cause of peritonitis (56.67%),most peritonitis were gram-positive bacterial infection (79.41 %);while gram-negative bacteria were the main pathogens of diarrhea-induced peritonitis (52.63%).The cure rates of gram-positive bacteria, gram-negative bacteria,and negative-cultured peritonitis were 92.96%, 76.92%,and 86.21% respectively,difference was not statistically significant(χ2 =3.39,P =0.18).Conclusion Gram-positive bacteria are major pathogens in PD-related peritonitis,and are usually caused by the bacteria through dialy-sis catheter due to non-standard operation during dialysate exchange.First-generation cephalosporins are not recom-mended as empirical therapy against gram-positive bacteria,while vancomycin is still the best choice.Third-genera-tion cephalosporins and aminoglycosides are recommended as empirical therapy against gram-negative bacteria. Gentamicin and levofloxacin can be used alone as empirical therapy in special circumstances.
出处 《中国感染控制杂志》 CAS 北大核心 2016年第10期739-743,共5页 Chinese Journal of Infection Control
关键词 腹膜透析 腹膜炎 病原菌 耐药性 抗药性 微生物 抗菌药物 peritoneal dialysis peritonitis pathogen drug resistance drug resistance,microbial antimicrobial agent
  • 相关文献

参考文献4

二级参考文献14

  • 1郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 2Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysisrelated infections recommendations: 2010 update. Petit Dial Int, 2010, 30: 393-423.
  • 3Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations:2010 update[J]. Petit Dial Int, 2010,30(4) : 393-423.
  • 4Yoon SH,Choi NW,Yun SR. Detecting bacterial growth in con- tiruous ambulatory peritoneal dialysis effluent using two culture methods[J]. Korean J Intern Med,2010,25(1) :82-85.
  • 5Shigidi MM, Fituri OM, Chandy SK, et al. Microbial spec- trum and outcome of peritoneal dialysis related peritonitis in Qatar[J]. Saudi J Kidney Dis Transpl, 2010,21 (1) : 168-173.
  • 6Strippoli GF,Tong A,Johnson D,et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004,18 (4) :CD004679.
  • 7Lui SL, Cheng SW, Ng SY, et al. Cefazolin plus netilmicin versus cefazolin plus eeftazidime for treating CAPD peritonitis: effect on residual renal function[J]. Kidney Int,2005,68(5) :2375-2380.
  • 8Lafrance JP, Rahme E, Iqbal S, et al. Association of dialysis modality with risk for infection-related hospitalization:a propensity score-matched cohort analysis [ J ]. Clin J Am Soc Nephrol,2012,7 (10) :1598 - 1605.
  • 9Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations :2010 update [ J ]. Petit Dial Int, 2010,30 (4) : 393 - 423.
  • 10Basturk T, Koc Y, Unsal A, et al. Fungal peritonitis in peritoneal dialy- sis:a 10 year retrospective analysis in a single center [J ]. Eur Rev Med Pharmacol Sci ,2012,16 ( 12 ), 1696 - 1700.

共引文献52

同被引文献110

引证文献15

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部